Serratia marcescens

Antibiotic
% Susceptible
2010
% Susceptible
2012
% Susceptible
2014
% Susceptible
2016
% Susceptible
2018
Ampicillin
4
0 0 0 0
Azithromycin
-
-
-
- -
Aztreonam
94
97
96
96 93
Cefazolin
0
0
0
0 0
Cefepime
96
100
100
100 100
Ceftazidime
92
89
97
96 91
Ceftriaxone
97
99
93
94 89
Cefuroxime
0
0
0
0 0
Ciprofloxacin
93
91
96
95 94
Clarithromycin
-
-
-
- -
Clindamycin
-
-
-
- -
Doxycycline
16
14
15
- -
Erythromycin
-
-
-
- -
Gentamicin
99
99
99
99 99
Imipenem
99
99
97
99 99
Levofloxacin 95 96 99 98 94
Meropenem + 99 99 100 100
Moxifloxacin + + + + +
Nitrofurantoin 0 0 0 0 0
Oxacillin/Naf - - - - -
Penicillin - - - - -
Piperacillin 83 93 77 + +
Piperacillin/tazo 93 92 93 96 91
Ticarcillin/Clav + + + + +
Tobramycin 93 89 93 97 93
TMP/SMX 94 99 99 97 99
Unasyn/Aug 3 0 0 0 0
Vancomycin - - - - -
       
# Tested 89 78 94 123 89

Comments:  

 

Numeric data represent local susceptibility data.
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections